DE69313872T2 - Verbindung von nucleocidanaloga zur behandlung viraler infektionen - Google Patents

Verbindung von nucleocidanaloga zur behandlung viraler infektionen

Info

Publication number
DE69313872T2
DE69313872T2 DE69313872T DE69313872T DE69313872T2 DE 69313872 T2 DE69313872 T2 DE 69313872T2 DE 69313872 T DE69313872 T DE 69313872T DE 69313872 T DE69313872 T DE 69313872T DE 69313872 T2 DE69313872 T2 DE 69313872T2
Authority
DE
Germany
Prior art keywords
nucleocid
analogs
connection
viral infections
treating viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69313872T
Other languages
English (en)
Other versions
DE69313872D1 (de
Inventor
Tarek Des Prairies Bou Mansour
Alan Tse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
IAF BioChem International Inc
Biochem Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IAF BioChem International Inc, Biochem Pharma Inc filed Critical IAF BioChem International Inc
Application granted granted Critical
Publication of DE69313872D1 publication Critical patent/DE69313872D1/de
Publication of DE69313872T2 publication Critical patent/DE69313872T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69313872T 1992-12-24 1993-12-22 Verbindung von nucleocidanaloga zur behandlung viraler infektionen Expired - Fee Related DE69313872T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226927A GB9226927D0 (en) 1992-12-24 1992-12-24 Dideoxy nucleoside analogues
PCT/CA1993/000563 WO1994014456A1 (en) 1992-12-24 1993-12-22 Use of dideoxy nucleoside analogues in the treatment of viral infections

Publications (2)

Publication Number Publication Date
DE69313872D1 DE69313872D1 (de) 1997-10-16
DE69313872T2 true DE69313872T2 (de) 1998-01-08

Family

ID=10727197

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69313872T Expired - Fee Related DE69313872T2 (de) 1992-12-24 1993-12-22 Verbindung von nucleocidanaloga zur behandlung viraler infektionen

Country Status (21)

Country Link
US (1) US6156737A (de)
EP (2) EP0675724B1 (de)
JP (2) JP2818299B2 (de)
KR (1) KR100331714B1 (de)
AP (1) AP450A (de)
AT (1) ATE157877T1 (de)
AU (1) AU681370B2 (de)
CA (1) CA2143204C (de)
DE (1) DE69313872T2 (de)
DK (1) DK0675724T3 (de)
ES (1) ES2108969T3 (de)
GB (1) GB9226927D0 (de)
GR (1) GR3024699T3 (de)
HK (1) HK1002426A1 (de)
IL (1) IL108063A (de)
MY (1) MY127808A (de)
NZ (1) NZ259487A (de)
RU (1) RU2160108C2 (de)
SG (1) SG48956A1 (de)
WO (1) WO1994014456A1 (de)
ZA (1) ZA939677B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728575A (en) * 1990-02-01 1998-03-17 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US5817667A (en) * 1991-04-17 1998-10-06 University Of Georgia Research Foudation Compounds and methods for the treatment of cancer
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
US20020120130A1 (en) 1993-09-10 2002-08-29 Gilles Gosselin 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents
CA2171550C (en) 1993-09-10 2008-08-26 Raymond F. Schinazi Nucleosides with anti-hepatitis b virus activity
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
IL115156A (en) 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US6391859B1 (en) * 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US5869461A (en) * 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
ES2276404T3 (es) * 1995-06-07 2007-06-16 Emory University Nucleosidos con actividad antivirus de la hepatitis-b.
US6100301A (en) * 1996-02-28 2000-08-08 Pfizer Inc Combination therapy to treat osteoporosis-polyphosphonates and estrogen agonists
US5753789A (en) * 1996-07-26 1998-05-19 Yale University Oligonucleotides containing L-nucleosides
ZA984796B (en) * 1997-06-10 1998-12-29 Chong Kun Dang Corp Novel optically active nucleoside derivative its manufacturing method and anti-HBV composition containing the derivative thereof
US7635690B2 (en) 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7115584B2 (en) * 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
ATE108794T1 (de) * 1985-05-15 1994-08-15 Wellcome Found Therapeutische nucleoside und deren herstellung.
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
IL85778A0 (en) * 1987-03-20 1988-09-30 Bristol Myers Co Production of 2',3'-dideoxynucleosides and certain such novel compounds
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
CA1327000C (en) * 1987-08-07 1994-02-15 David L.J. Tyrrell Antiviral therapy for hepatitis b
US5039667A (en) * 1987-08-07 1991-08-13 The Governors Of The University Of Alberta Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
SE8802687D0 (sv) * 1988-07-20 1988-07-20 Astra Ab Nucleoside derivatives
AU5659990A (en) * 1989-05-15 1990-12-18 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method of treatment of hepatitis
SE464168B (sv) * 1989-07-19 1991-03-18 Bo Fredrik Oeberg Antiviral komposition bestaaende av en 3'-fluoro-2',3'-dideoxynukleosidfoerening och en 2',3'-dideoxynukleosidfoerening (exempelvis azt)
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
US5179104A (en) * 1990-12-05 1993-01-12 University Of Georgia Research Foundation, Inc. Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
IL100965A (en) * 1991-02-22 1999-12-31 Univ Emory 2 - Hydroxymethyl - 5 -) 5 - Fluorocytocin - 1 - Eyal (- 1, 3 - Oxathiolane, its resolution and pharmaceuticals containing it
AU662130B2 (en) * 1991-03-06 1995-08-24 Emory University Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis B
WO1992018517A1 (en) * 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
TW374087B (en) * 1993-05-25 1999-11-11 Univ Yale L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents
JPH09222548A (ja) * 1996-02-19 1997-08-26 Asahi Optical Co Ltd レンズ駆動機構

Also Published As

Publication number Publication date
AP9300603A0 (en) 1994-01-31
ATE157877T1 (de) 1997-09-15
IL108063A (en) 1999-10-28
KR100331714B1 (ko) 2002-11-01
RU2160108C2 (ru) 2000-12-10
AP450A (en) 1996-01-19
IL108063A0 (en) 1994-04-12
HK1002426A1 (en) 1998-08-21
ES2108969T3 (es) 1998-01-01
CA2143204C (en) 1997-06-03
MY127808A (en) 2006-12-29
JPH10139668A (ja) 1998-05-26
JP2818299B2 (ja) 1998-10-30
GB9226927D0 (en) 1993-02-17
DK0675724T3 (da) 1998-03-09
EP0765665A1 (de) 1997-04-02
EP0675724B1 (de) 1997-09-10
GR3024699T3 (en) 1997-12-31
AU681370B2 (en) 1997-08-28
EP0675724A1 (de) 1995-10-11
ZA939677B (en) 1994-08-26
AU5830194A (en) 1994-07-19
JPH07509730A (ja) 1995-10-26
CA2143204A1 (en) 1994-07-07
SG48956A1 (en) 1998-05-18
WO1994014456A1 (en) 1994-07-07
NZ259487A (en) 1997-06-24
DE69313872D1 (de) 1997-10-16
US6156737A (en) 2000-12-05

Similar Documents

Publication Publication Date Title
DE69313872T2 (de) Verbindung von nucleocidanaloga zur behandlung viraler infektionen
DE69318433T2 (de) Verfahren zur Behandlung von Verbrennungsabgasen
DE69115920T2 (de) Verfahren zur Behandlung von schmelzgeblasenen Filamenten
DK156688D0 (da) Praeparat til behandling af virusinfektioner
DE69214610D1 (de) Verfahren zur Behandlung von Erdgas
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
NO940810D0 (no) Behandling av virusinfeksjoner
DE69216089T2 (de) Behandlung von aluminiumblechen
DE69103214D1 (de) Verfahren zur Reinigung von Glycin.
DE69304687T2 (de) Verfahren zur Herstellung von Ethylbenzol
DE69131769T2 (de) Verfahren zur Herstellung von Ethylbenzol
DE69301936D1 (de) Verfahren zur Behandlung von Rauchgas
DE69311213D1 (de) Verfahren zur Herstellung von 1-Aza-2-silacyclopentan-Verbindungen
DE59309654D1 (de) Verfahren zur Herstellung von festem Natriumcyanid
DE69306831T2 (de) Behandlung von Flüssigkeiten
DE69309373T2 (de) Verfahren zur Herstellung von aromatischer sekundärer Amino Verbindung
DE69318644T2 (de) Behandlung von Flüssigkeiten
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE69300700D1 (de) Verfahren zur Lösung von 3-Dimethylamino-2-Methylpropiophenon (3-Damp).
DE69300712T2 (de) Verfahren zur Reinigung von L-Phenylalanin.
DE69314086T2 (de) Verfahren zur Reinigung von 4,4'-Diaminodiphenylmethan
DE69205341D1 (de) Verfahren zur Reinigung von Diaminodiphenylverbindungen.
DE69430569T2 (de) Carbocyclischen deoxyguanosinanaloga zur behandlung von viralen infektionen
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
DE69413325T2 (de) 24-Epi-1alpha-Hydroxyvitamin D2 zur Behandlung von Osteoporosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SHIRE BIOCHEM INC., ST.LAURENT, QUEBEC, CA

8327 Change in the person/name/address of the patent owner

Owner name: SHIRE CANADA INC., ST. LAURENT, QUEBEC, CA

8339 Ceased/non-payment of the annual fee